The DOI matches its Crossref record.
Body Mass Index in Midlife and Risk of Alzheimer Disease and Vascular Dementia
Abstract
Prior work has suggested that obesity and overweight as measured by body mass index (BMI) increases risk of dementia. It is unknown if there is a difference in the risk of developing Alzheimer disease (AD) versus vascular dementia (VaD) associated with high body weight. The goal of this study was to examine the association between midlife BMI and risk of both AD and VaD an average of 36 years later in a large (N= 10,136) and diverse cohort of members of a health care delivery system. Participants aged 40-45 participated in health exams between 1964 and 1968. AD and VaD diagnoses were obtained from Neurology visits between January 1, 1994 and June 15, 2006. Those with diagnoses of general dementia from primary care providers were excluded from the study. BMI was analyzed in WHO categories of underweight, overweight and obese, as well as in subdivisions of WHO categories. All models were fully adjusted for age, education, race, sex, marital status, smoking, hyperlipidemia, hypertension, diabetes, ischemic heart disease and stroke. Cox proportional hazard models showed that compared to those with a normal BMI (18.5-24.9), those obese (BMI > or = 30) at midlife had a 3.10 fold increase in risk of AD (fully adjusted model, Hazard Ratio=3.10, 95% CI 2.19-4.38), and a five fold increase in risk of VaD (fully adjusted model, HR=5.01, 95% CI 2.98-8.43) while those overweight ( BMI > or = 25 and <30) had a two fold increase in risk of AD and VaD (fully adjusted model, HR=2.09, 95% CI 1.69-2.60 for AD and HR=1.95, 95% CI 1.29-2.96 for VaD). These data suggest that midlife BMI is strongly predictive of both AD and VaD, independent of stroke, cardiovascular and diabetes co morbidities. Future studies need to unveil the mechanisms between adiposity and excess risk of AD and VaD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the study of Whitmer et al.15 overweight (BMI between 25 and 30) increased the risk of AD and VaD to the same extent (approximately a two- fold increased risk), whereas obesity (BMI ≥ 30) was more strongly related to VaD, indicating a five-fold risk, as compared to a three-fold risk of AD.”
From Overweight in midlife and risk of dementia: a 40-year follow-up study (2009) · cites this paper as [15]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Exercise and Physical Activity for Older Adults
Chodzko-Zajko, W. J., Proctor, D. N., Fiatarone Singh, M. A., Minson, C. T., Nigg, C. R., Salem, G. J., & Skinner, J. S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181a0c95c · Cited by 5,153
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128
Self-citationMicroglia-mediated neuroinflammation in neurodegenerative diseases
Subhramanyam, C. S., Wang, C., Hu, Q., & Dheen, S. T. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.004 · Cited by 897
Anstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00825.x · Cited by 855
Central obesity and increased risk of dementia more than three decades later
Whitmer, R. A., Gustafson, D. R., Barrett-Connor, E., Haan, M. N., Gunderson, E. P., & Yaffe, K. (2008) · Neurology · doi:10.1212/01.wnl.0000306313.89165.ef · Cited by 803
Self-citationObesity and neuroinflammation: A pathway to cognitive impairment
Miller, A. A., & Spencer, S. J. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.001 · Cited by 834
Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders
Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 683
Beydoun, M. A., Beydoun, H. A., & Wang, Y. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00473.x · Cited by 563
Update on Alzheimer’s Disease Therapy and Prevention Strategies
Graham, W. V., Bonito-Oliva, A., & Sakmar, T. P. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-042915-103753 · Cited by 506
Midlife overweight and obesity increase late-life dementia risk
Xu, W., Atti, A. R., Gatz, M., Pedersen, N. L., Johansson, B. E. A., & Fratiglioni, L. (2011) · Neurology · doi:10.1212/wnl.0b013e3182190d09 · Cited by 498
Pedditizi, E., Peters, R. K., & Beckett, N. S. (2016) · Age and Ageing · doi:10.1093/ageing/afv151 · Cited by 476
Sirtuin 1 Reduction Parallels the Accumulation of Tau in Alzheimer Disease
Julien, C., Tremblay, C., Émond, V., Lebbadi, M., Salem, N., Bennett, D. A., & Calon, F. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181922348 · Cited by 475
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 472
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
de la Monte, S. M. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 468
Midlife vs Late-Life Depressive Symptoms and Risk of Dementia
Yaffe, K. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1481 · Cited by 468
Self-citationSantos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
Horton, W. B., & Barrett, E. J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa025 · Cited by 461
Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II study
Singh‐Manoux, A., Dugravot, A., Shipley, M., Brunner, E. J., Elbaz, A., Sabia, S., & Kivimaki, M. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.06.2637 · Cited by 401
Examining the relationship between obesity and cognitive function: A systematic literature review
Prickett, C., Brennan, L., & Stolwyk, R. J. (2014) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2014.05.001 · Cited by 395
van den Berg, E., Kloppenborg, R. P., Kessels, R. P. C., Kappelle, L. J., & Biessels, G. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.004 · Cited by 373
Kim, B., & Feldman, E. L. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.3 · Cited by 372
The role of gut hormones and the hypothalamus in appetite regulation
Suzuki, K., Simpson, K. A., MINNION, J. S., Shillito, J. C., & Bloom, S. R. (2010) · Endocrine Journal · doi:10.1507/endocrj.k10e-077 · Cited by 327
Metabolic Dysfunction in Alzheimers Disease and Related Neurodegenerative Disorders
Cai, H., Cong, W., Ji, S., Rothman, S. M., Maudsley, S. R., & Martin, B. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015064 · Cited by 302
Interplay between the gut-brain axis, obesity and cognitive function
Agustí, A., García-Pardo, M. P., López-Almela, I., Campillo, I., Maes, M., Romaní-Pérez, M., & Sanz, Y. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00155 · Cited by 294
Vascular basis for brain degeneration: faltering controls and risk factors for dementia
Kalaria, R. N. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00352.x · Cited by 300
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K. R. K., Høilund‐Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 315
Albanese, E., Launer, L. J., Egger, M., Prince, M. J., Giannakopoulos, P., Wolters, F. J., & Egan, K. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.05.007 · Cited by 272
The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE
Guerreiro, R. J., Gustafson, D. R., & Hardy, J. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.025 · Cited by 285
Adipokines: a link between obesity and dementia?
Kiliaan, A. J., Arnoldussen, I. A. C., & Gustafson, D. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70085-7 · Cited by 290
Pedditzi, E., Peters, R. K., & Beckett, N. S. (2016) · Age and Ageing · doi:10.1093/ageing/afw095 · Cited by 279
de la Monte, S. M. (2012) · Drugs · doi:10.2165/11597760-000000000-00000 · Cited by 265
Tolppanen, A., Ngandu, T., Kåreholt, I., Laatikainen, T. K., Rusanen, M., Soininen, H. S., & Kivipelto, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130698 · Cited by 258
Systematic review of health behavioral risks and cognitive health in older adults
Lee, Y., Back, J. H., Kim, J., Kim, S.-H., Na, D. L., Cheong, H., Hong, C. H., & Kim, Y. G. (2009) · International Psychogeriatrics · doi:10.1017/s1041610209991189 · Cited by 250
Knight, E. M., Martins, I. V. A., Gümüsgöz, S., Allan, S. M., & Lawrence, C. B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.010 · Cited by 232
Insulin Resistance in Alzheimer's Disease
Ferreira, L. S. S., Fernandes, C., Vieira, M. N. N., & Felice, F. G. D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00830 · Cited by 238
Future directions in Alzheimer's disease from risk factors to prevention
Imtiaz, B., Tolppanen, A., Kivipelto, M., & Soininen, H. S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.003 · Cited by 249
Qu, Y., Hu, H.-Y., Ou, Y.-N., Shen, X.-N., Xu, W., Wang, Z.-T., Dong, Q., Tan, L., & Yu, J.-T. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.012 · Cited by 240
Obesity and dementia: Adipokines interact with the brain
Arnoldussen, I. A. C., Kiliaan, A. J., & Gustafson, D. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.03.002 · Cited by 226
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215
Association between late-life body mass index and dementia
Hughes, T. F., Borenstein, A. R., Schofield, E., Wu, Y., & Larson, E. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a60a58 · Cited by 220
Safiri, S., Jolfayi, A. G., Fazlollahi, A., Morsali, S., Sarkesh, A., Sorkhabi, A. D., Golabi, B., Aletaha, R., Asghari, K. M., Hamidi, S., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1474043 · Cited by 273
Blalock, E. M., Buechel, H. M., Popovic, J., Geddes, J. W., & Landfield, P. W. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.06.007 · Cited by 211
Promoting Successful Cognitive Aging: A Comprehensive Review
Daffner, K. R. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1306 · Cited by 231
Cognitive decline, dietary factors and gut–brain interactions
Caracciolo, B., Xu, W., Collins, S. M., & Fratiglioni, L. (2013) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2013.11.011 · Cited by 213
Obesity is linked with lower brain volume in 700 AD and MCI patients
Ho, A. J., Raji, C. A., Becker, J. T., López, O. L., Kuller, L. H., Hua, X., Lee, S., Hibar, D. P., Dinov, I. D., Stein, J. L., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.04.006 · Cited by 213
Overweight in midlife and risk of dementia: a 40-year follow-up study
Hassing, L. B., Dahl, A. K., Thorvaldsson, V, Berg, S., Gatz, M., Pedersen, N. L., & Johansson, B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.104 · Cited by 197
Mielke, M. M., Aggarwal, N. T., Vila‐Castelar, C., Agarwal, P., Arenaza‐Urquijo, E. M., Brett, B., Brugulat‐Serrat, A., DuBose, L. E., Eikelboom, W. S., Flatt, J., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12662 · Cited by 198
Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration
Spielman, L. J., Little, J. P., & Klegeris, A. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.06.004 · Cited by 182
Bischof, G. N., & Park, D. C. (2015) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000212 · Cited by 189
Naderali, E. K., Ratcliffe, S. H., & Dale, M. C. (2009) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317509348208 · Cited by 187
Cognitive Function and Decline in Obesity
Stanek, K. M., & Gunstad, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111073 · Cited by 178
Loef, M., & Walach, H. (2013) · Obesity · doi:10.1002/oby.20037 · Cited by 178
Morys, F., Dadar, M., & Dagher, A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab135 · Cited by 181
Calvo‐Ochoa, E., Hernández‐Ortega, K., Ferrera, P., Morimoto, S., & Arias, C. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.48 · Cited by 158
Adiposity indicators and dementia over 32 years in Sweden
Gustafson, D., Bäckman, K., Wærn, M., Östling, S., Guo, X., Zandi, P. P., Mielke, M. M., Bengtsson, C., & Skoog, I. G. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0d4b6 · Cited by 156
Haring, B., Leng, X., Robinson, J. G., Johnson, K., Jackson, R. D., Beyth, R. J., Wactawski‐Wende, J., von Ballmoos, M. C. W., Goveas, J. S., Kuller, L. H., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000369 · Cited by 162
Puig, K. L., Floden, A. M., Adhikari, R., Golovko, M. Y., & Combs, C. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030378 · Cited by 152
Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Hughes, T. F., & Ganguli, M. (2009) · Current Psychiatry Reviews · doi:10.2174/157340009788167347 · Cited by 155
Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus
Moroz, N., Tong, M., Longato, L., Xu, H., & de la Monte, S. M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15103 · Cited by 151
Meng, X.-F., Yu, J.-T., Wang, H.-F., Tan, M.-S., Wang, C., Tan, C.-C., & Tan, L. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140954 · Cited by 150
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154
Maesako, M., Uemura, K., Kubota, M., Kuzuya, A., Sasaki, K., Hayashida, N., Asada-Utsugi, M., Watanabe, K., Uemura, M., Kihara, T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.367011 · Cited by 141
The role of nutrition in Alzheimer’s disease: epidemiological evidence
Morris, M. C. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02735.x · Cited by 151
Obesity and Lowered Cognitive Performance in a Canadian First Nations Population
Salerno, J., Bruce, S. G., Lou, W. Y. W., Hanley, A. J., Greenwood, C. E., & Young, T. K. (2009) · Obesity · doi:10.1038/oby.2009.161 · Cited by 143
Sex differences in risk factors for vascular contributions to cognitive impairment & dementia
Gannon, O. J., Robison, L. S., Custozzo, A. J., & Zuloaga, K. L. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.11.014 · Cited by 146
Sekita, A., Ninomiya, T., Tanizaki, Y., Doi, Y., Hata, J., Yonemoto, K., Arima, H., Sasaki, K., Iida, M., Iwaki, T., et al. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01587.x · Cited by 143
Vascular Cognitive Impairment: Disease Mechanisms and Therapeutic Implications
Levine, D. A., & Langa, K. M. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0047-z · Cited by 131
Treatment Options in Alzheimer’s Disease: Maximizing Benefit, Managing Expectations
Farlow, M. R., Miller, M. L., & Pejović, V. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000122962 · Cited by 131
Obesity, leptin, and Alzheimer's disease
Lee, E. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06274.x · Cited by 126
Variations in the neuropathology of familial Alzheimer’s disease
Shepherd, C. E., McCann, H., & Halliday, G. M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0521-4 · Cited by 135
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
Lakhan, S. E., & Kirchgessner, A. L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-129 · Cited by 133
Gannon, O. J., Robison, L. S., Salinero, A. E., Abi-Ghanem, C., Mansour, F. M., Kelly, R. D., Tyagi, A., Brawley, R. R., Ogg, J. D., & Zuloaga, K. L. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02466-2 · Cited by 127
Shefer, G., Marcus, Y., & Stern, N. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.07.015 · Cited by 128
Alzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123
Diseases and disorders associated with excess body weight.
Knight, J. A. (2011) · PubMed · Cited by 122
Gonzales, M. M., Tarumi, T., Miles, S. C., Tanaka, H., Shah, F., & Haley, A. P. (2010) · Obesity · doi:10.1038/oby.2010.183 · Cited by 129
Barron, A. M., Rosario, E. R., Elteriefi, R., & Pike, C. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078554 · Cited by 117
A life course of adiposity and dementia
Gustafson, D. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.052 · Cited by 120
Venkatrao, M., Nagarathna, R., Majumdar, V., Patil, S. S., Rathi, S., & Nagendra, H. R. (2020) · Annals of Neurosciences · doi:10.1177/0972753120987465 · Cited by 129
Body mass index and cognitive function: the potential for reverse causation
Suemoto, C. K., Gilsanz, P., Mayeda, E. R., & Glymour, M. M. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.83 · Cited by 118
Greendale, G. A., Derby, C. A., & Maki, P. M. (2011) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2011.05.007 · Cited by 122
Walker, J. M., Dixit, S., Saulsberry, A. C., May, J. M., & Harrison, F. E. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.01.004 · Cited by 110
Slowing the progression of Alzheimer’s disease; what works?
Nelson, L., & Tabet, N. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.07.002 · Cited by 117
Fatty acids, lipid metabolism and Alzheimer pathology
Hooijmans, C. R., & Kiliaan, A. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.081 · Cited by 115
Beydoun, M. A., Lhotsky, A., Wang, Y., Forno, G. D., An, Y., Metter, E. J., Ferrucci, L., O’Brien, R., & Zonderman, A. B. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn229 · Cited by 111
Vascular Dementia and Underlying Sex Differences
Akhter, F., Persaud, A., Zaokari, Y., Zhao, Z., & Zhu, D. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.720715 · Cited by 119
Multi-domain interventions for the prevention of dementia and cognitive decline
Hafdi, M., Hoevenaar-Blom, M. P., & Richard, E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013572.pub2 · Cited by 124
Post‐traumatic stress disorder and risk of dementia among members of a health care delivery system
Flatt, J. D., Gilsanz, P., Quesenberry, C. P., Albers, K. B., & Whitmer, R. A. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.04.014 · Cited by 105
Self-citationIs Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum
Ríos, J. A., Cisternas, P., Arrese, M. A., Salesa Barja, Y., & Inestrosa, N. C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.07.004 · Cited by 107
Models and mechanisms for hippocampal dysfunction in obesity and diabetes
Stranahan, A. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.045 · Cited by 104
Casson, I. R., Viano, D. C., Haacke, E. M., Kou, Z., & LeStrange, D. G. (2014) · Sports Health A Multidisciplinary Approach · doi:10.1177/1941738114540270 · Cited by 113
Effect of Apolipoprotein E Genotype and Diet on Apolipoprotein E Lipidation and Amyloid Peptides
Hanson, A. J., Bayer-Carter, J. L., Green, P. S., Montine, T. J., Wilkinson, C. W., Baker, L. D., Watson, G. S., Bonner, L. M., Callaghan, M., Leverenz, J. B., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.396 · Cited by 110
Pathways linking obesity to neuropsychiatric disorders
Martins, L. B., Monteze, N. M., Calarge, C. A., Ferreira, A. V. M., & Teixeira, A. L. (2019) · Nutrition · doi:10.1016/j.nut.2019.03.017 · Cited by 110
Obesity-Induced Brain Neuroinflammatory and Mitochondrial Changes
Schmitt, L. O., & Gaspar, J. M. (2023) · Metabolites · doi:10.3390/metabo13010086 · Cited by 112
Mitochondria in Alzheimer's disease and their potential role in Alzheimer's proteostasis
Weidling, I. W., & Swerdlow, R. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113321 · Cited by 104
de la Monte, S. M., Neusner, A. D., Chu, J., & Lawton, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1070 · Cited by 98
The Impact of Genetic Research on our Understanding of Normal Cognitive Ageing: 1995 to 2009
Payton, A. (2009) · Neuropsychology Review · doi:10.1007/s11065-009-9116-z · Cited by 95
Metadata
- Authors
- Whitmer, R., Gunderson, E., Quesenberry, C., Zhou, J., & Yaffe, K.
- Affiliations
- Kaiser Permanente (US)
- University of California, San Francisco (US)
- Venue
- Current Alzheimer Research
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2007-04-01
- Volume
- 4
- Issue
- 2
- Pages
- 103-109
- ISSN
- 1567-2050 (ISSN-L)
- OpenAlex
- W2139377504
- Cited by
- 430
- References
- 0
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 20 · 2023: 18 · 2022: 17 · 2021: 26 · 2020: 27 · 2019: 16 · 2018: 23 · 2017: 29 · 2016: 26 · 2015: 20 · 2014: 46 · 2013: 29 · 2012: 30
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Alzheimer Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG027504, R03AG027504)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK066308, DK066308)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- body mass index, midlife obesity, overweight, Alzheimer's disease, vascular dementia, dementia risk, adiposity, stroke, cardiovascular comorbidity, diabetes mellitus
- MeSH terms
- Adult, Alzheimer Disease, Body Weight, Female, Humans, Male, Middle Aged, Retrospective Studies, Risk, Dementia, Vascular, Body Mass Index, Incidence, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review